Concord Biotech Company Description
Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally.
The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas.
It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus for immunosuppressants therapeutic segment; temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, dactinomycin, staurosporin, mitoguazone, and everolimus premix for oncology therapeutic segment; mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, micafungin sodium, amphotericin B, and nystatin for anti-fungal therapeutic segment; and lovastatin, pravastatin sodium, and enzymes for other applications.
In addition, it provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products.
Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.
Country | India |
Founded | 1984 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 1,377 |
CEO | Ankur Vaid |
Contact Details
Address: 16th Floor, B-Wing Ahmedabad, Gujarat 380015 India | |
Phone | 91 79 6813 8700 |
Website | concordbiotech.com |
Stock Details
Ticker Symbol | CONCORDBIO |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Ankur Vaid | Joint MD, Chief Executive Officer and Director |
Sudhir Jairam Vaid | Chairman and MD |
Lalit Sethi | Chief Financial Officer |
Prakash Lalchand Sajnani | Company Secretary, Compliance Officer and Assistant Vice President of Finance |
Devang Bhatt | Vice President of Sales and Marketing and Head of Limbasi Plant-3 |
Manoj Kumar | Vice President of Formulation Division and Head of Valthera Unit-2 |
Sundeep Bengani | General Manager, International Business Development |